Seoul — October 08, 2026. Published after the market close; index and stock prices are official closing values. Currency levels are market quotes, not official closes.
The 30-second version
- The KOSPI closed at 6,625.93, down 2.62% — one of its sharpest daily drops of 2026 — even as Samsung Electronics reported the first 100-trillion-won quarterly operating profit in Korean corporate history.
- Foreign investors sold a net 2.44 trillion won (about $1.8 billion) of KOSPI shares and institutions another 1.93 trillion won (about $1.4 billion). Retail investors bought 3.60 trillion won (about $2.7 billion) but could not absorb it all.
- Goldman Sachs had warned in advance of a “triple whammy”: sell-on-news pressure around Samsung’s results, options expiry, and the scheduled rebalancing of seven semiconductor ETFs with roughly $14 billion in combined assets.
- The KOSDAQ held up far better, slipping just 0.69% to 892.27 as battery stocks rallied on strong earnings. Biotech was the day’s casualty: Peptron collapsed 29.94% on uncertainty over its Eli Lilly partnership.
- The won was little changed, with USD/KRW trading around 1,340 at the end of the session.
A record profit met a wall of mechanical selling
On paper, this should have been Samsung Electronics’ day. The company reported third-quarter revenue of 195 trillion won (roughly $146 billion at today’s rate) and operating profit of 107.4 trillion won — up 782.5% from a year earlier, up 20% from the previous quarter, and the first time any Korean company has cleared 100 trillion won in operating profit in a single quarter. Management also flagged that HBM4 shipments are ramping, with HBM bit growth expected to rise about 50% versus the prior quarter.
The stock fell 2.42% to 262,000 won. SK hynix dropped 2.44% to 1,681,000 won. The index battled around the 6,751 level intraday before sliding into the close.
Why? Because the result was so widely anticipated that it became a liquidity event rather than a surprise. Three things collided. First, classic “sell-on-news” behavior: investors who bought ahead of the announcement took profits once the number was confirmed. Second, today was an options expiry day — the session when index options contracts settle, which routinely forces derivatives-linked positions to be unwound or rolled, generating selling that has nothing to do with fundamentals. Third, seven semiconductor-focused ETFs managing around $14 billion were conducting their regular rebalancing, adding another layer of mechanical flow. Goldman Sachs had publicly warned about this “triple whammy” the day before, so the volatility was telegraphed even if the magnitude was not. Lingering worries that semiconductor earnings are near a “peak-out” — and that growth in Big Tech data-center capital spending is set to slow — gave sellers an additional narrative to lean on.
The damage spread through the large-cap complex: SK Square fell 8.06%, Samsung C&T 5.51%, and Samsung Biologics 4.54%, according to the Newspim closing recap.
Retail bought the dip — alone
The flow picture was stark. On the KOSPI, retail investors bought a net 3.60 trillion won while foreigners and institutions together dumped over 4 trillion won (roughly $3.3 billion). Korean market commentary called it a one-sided “human shield” defense — and it was not enough to hold the 6,700 line. Notably, the selling hit both cash equities and futures simultaneously, a sign of broad de-risking rather than single-stock rotation.
The KOSDAQ told a different story: retail (+48.7 billion won) and foreigners (+55.8 billion won) were both modest net buyers there, with only institutions selling (-96.2 billion won). That split explains why the smaller market lost just 0.69% on a day the KOSPI fell 2.62%.
Batteries celebrated earnings; biotech absorbed a shock
Secondary batteries were the day’s strongest theme, with the theme index up 3.2% and lithium names up 2.55%. The catalyst was earnings: LG Energy Solution posted third-quarter revenue of 9.64 trillion won (up 58.99% year over year) and operating profit of 756 billion won (up 25.72%), lifting the stock 2.56%. Samsung SDI is expected to beat consensus with operating profit of 257.5 billion won. EcoPro BM gained 3.45%, Dawonnexview surged 17%, and a broad swath of materials and component names — along with battery-parts suppliers up 3-5% — followed. Among semiconductor equipment makers on the KOSDAQ, Jusung Engineering jumped 8.08%.
Pharma and biotech went the other way. A European court ruling blocking sales of Merck’s subcutaneous Keytruda in eight countries weighed on the whole sector. The headline casualty was Peptron, which crashed 29.94% — near the daily limit — after its two-year technology evaluation with Eli Lilly for the “SmartDepot” long-acting drug-delivery platform ended on October 7 without a commercialization contract being announced alongside it. The market read the silence as a dead deal. Peptron pushed back after the close, saying it is “inappropriate” to interpret the evaluation’s completion as a failed commercialization, leaving the door open to further disclosures. Alteogen fell 5.45%, breaking below the 300,000-won level, and names including Inventage Lab, Qurient, Shinpoong Pharm, Hanmi Pharmaceutical, and LigaChem Biosciences lost around 10% each.
The numbers that matter
| Item | Close | Change |
|---|---|---|
| KOSPI | 6,625.93 | -177.97 pts (-2.62%) |
| KOSDAQ | 892.27 | -6.16 pts (-0.69%) |
| USD/KRW | Around 1,340 (quote, not an official close) | Little changed |
| KOSPI retail net flow | +3.60T won (~$2.7B) | Net buy |
| KOSPI foreign net flow | -2.44T won (~$1.8B) | Net sell |
| KOSPI institutional net flow | -1.93T won (~$1.4B) | Net sell |
| Samsung Electronics | 262,000 won | -2.42% |
| SK hynix | 1,681,000 won | -2.44% |
What to watch next
- Samsung’s guidance and conference call. The market flagged this as the decisive watershed: a confident message could spark a rebound in semiconductor large caps, while a cautious one would likely accelerate rotation into batteries and KOSDAQ names.
- Peptron disclosures. The company has hinted at further announcements regarding a possible follow-on contract with Eli Lilly.
- Whether mechanical pressure fades. With options expiry and the semiconductor ETF rebalancing now behind the market, the next sessions will show how much of today’s selling was structural versus fundamental.
- The “peak-out” debate. Concerns about slowing growth in Big Tech data-center capex remain the main overhang on chip sentiment.
FAQ
Why did the KOSPI fall after Samsung’s record earnings?
Because the beat was expected and the session was crowded with forced flows. Profit-taking on the news coincided with options expiry — the day derivatives contracts settle, triggering mechanical position unwinds — and the rebalancing of seven semiconductor ETFs holding about $14 billion. Foreigners and institutions sold over $3 billion combined.
What does “sell-on-news” mean?
It describes investors buying ahead of an anticipated positive event and selling once it is confirmed. The good news is already “in the price,” so the announcement itself becomes the exit, not the entry. Samsung falling 2.42% on a record quarter is a textbook example.
Why did Peptron drop almost 30%?
Its technology evaluation with Eli Lilly ended on October 7 without a commercialization deal announced at the same time, and investors treated that silence as a collapsed partnership. The company disputes that reading, so the stock is now trading on headline risk around any follow-up disclosure.
Did the Korean won react to the selloff?
Barely. USD/KRW was little changed on the day, trading around 1,340 — suggesting today’s equity move was driven by positioning and mechanics rather than a broader flight from Korean assets.
Disclaimer: This is an information and analysis publication, not investment advice. See our Methodology for data sources, standards, and our corrections policy.
Also on Seoul Closing Bell
A companion piece on the same session, written from a different angle: Samsung's 100 Trillion Won Quarter Became a Sell Signal.